Aptorum Group Limited is a biotechnology business based in the US. Aptorum Group shares (APM) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in Aptorum Group
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – APM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- APM shares summary
- Compare share dealing platforms
- Is APM stock a buy or sell?
- Stock performance over time
- Can I short APM shares?
- Are APM shares over-valued?
- Aptorum Group's financials
- How volatile are APM shares?
- Does Aptorum Group pay a dividend?
- Have APM shares ever split?
- Other common questions
Aptorum Group stock price (NASDAQ: APM)Use our graph to track the performance of APM stocks over time.
Aptorum Group shares at a glance
|Latest market close||$2.80|
|52-week range||$1.16 - $4.56|
|50-day moving average||$3.02|
|200-day moving average||$3.00|
|Wall St. target price||$13.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.20|
Buy Aptorum Group shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Aptorum Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aptorum Group price performance over time
|1 week (2021-07-19)||N/A|
|1 month (2021-06-30)||-12.36%|
|3 months (2021-04-30)||6.06%|
|6 months (2021-01-26)||N/A|
|1 year (2020-07-26)||N/A|
|2 years (2019-07-26)||N/A|
|3 years (2018-07-26)||N/A|
|5 years (2016-07-26)||N/A|
Is Aptorum Group under- or over-valued?
Valuing Aptorum Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aptorum Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aptorum Group's P/E ratio
Aptorum Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Aptorum Group shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Aptorum Group financials
|Gross profit TTM||$-103,514|
|Return on assets TTM||-36.11%|
|Return on equity TTM||18.57%|
|Market capitalisation||$94 million|
TTM: trailing 12 months
Shorting Aptorum Group shares
There are currently 317,358 Aptorum Group shares held short by investors – that's known as Aptorum Group's "short interest". This figure is 63% up from 194,718 last month.
There are a few different ways that this level of interest in shorting Aptorum Group shares can be evaluated.
Aptorum Group's "short interest ratio" (SIR)
Aptorum Group's "short interest ratio" (SIR) is the quantity of Aptorum Group shares currently shorted divided by the average quantity of Aptorum Group shares traded daily (recently around 406869.23076923). Aptorum Group's SIR currently stands at 0.78. In other words for every 100,000 Aptorum Group shares traded daily on the market, roughly 780 shares are currently held short.
However Aptorum Group's short interest can also be evaluated against the total number of Aptorum Group shares, or, against the total number of tradable Aptorum Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aptorum Group's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Aptorum Group shares in existence, roughly 10 shares are currently held short) or 0.0446% of the tradable shares (for every 100,000 tradable Aptorum Group shares, roughly 45 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aptorum Group.
Find out more about how you can short Aptorum Group stock.
Aptorum Group share dividends
We're not expecting Aptorum Group to pay a dividend over the next 12 months.
Have Aptorum Group's shares ever split?
Aptorum Group's shares were split on a 3:1 basis on 1 May 2011. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Aptorum Group shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Aptorum Group shares which in turn could have impacted Aptorum Group's share price.
Aptorum Group share price volatility
Over the last 12 months, Aptorum Group's shares have ranged in value from as little as $1.16 up to $4.56. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aptorum Group's is -0.2101. This would suggest that Aptorum Group's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aptorum Group has bucked the trend.
Aptorum Group overview
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. .
Stocks similar to Aptorum Group
Aptorum Group in the news
What Kind Of Shareholders Hold The Majority In Aptorum Group Limited's (NASDAQ:APM) Shares?
Aptorum Shares Move Higher After Interim Data From Staphylococcus Aureus Candidate
Aptorum Group Announces Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus
Frequently asked questionsWhat percentage of Aptorum Group is owned by insiders or institutions?
Currently 37.417% of Aptorum Group shares are held by insiders and 1.71% by institutions. When does the fiscal year end for Aptorum Group?
Aptorum Group's fiscal year ends in December. Where is Aptorum Group based?
Aptorum Group's address is: 17 Hanover Square, London, United Kingdom, W1S 1BN What is Aptorum Group's ISIN number?
Aptorum Group's international securities identification number is: KYG6096M1069 What is Aptorum Group's CUSIP number?
Aptorum Group's Committee on Uniform Securities Identification Procedures number is: G6096M106
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert